Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides

STAR Protoc. 2021 Sep 17;2(3):100635. doi: 10.1016/j.xpro.2021.100635. Epub 2021 Jun 9.

Abstract

Understanding T-cell responses requires identifying viral peptides presented by human leukocyte antigens (HLAs). X-ray crystallography can be used to visualize their presentation. This protocol describes the expression, purification, and crystallization of HLA-A∗02:01, one of the most frequent HLA in the global population in complex with peptides derived from the SARS-CoV-2 nucleocapsid protein. This protocol can be applied to different HLA class I molecules bound to other peptides. For complete details on the use and execution of this protocol, please refer to Szeto et al. (2021).

Keywords: Immunology; Protein expression and purification; X-ray Crystallography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / immunology
  • COVID-19 / metabolism*
  • COVID-19 / virology
  • Coronavirus Nucleocapsid Proteins / chemistry*
  • Coronavirus Nucleocapsid Proteins / isolation & purification
  • Coronavirus Nucleocapsid Proteins / metabolism
  • Crystallography, X-Ray
  • Epitopes, T-Lymphocyte / immunology
  • HLA-A2 Antigen / chemistry*
  • HLA-A2 Antigen / metabolism
  • Humans
  • Peptide Fragments / chemistry*
  • Peptide Fragments / isolation & purification
  • Peptide Fragments / metabolism
  • Phosphoproteins / chemistry
  • Phosphoproteins / isolation & purification
  • Phosphoproteins / metabolism
  • SARS-CoV-2 / metabolism*
  • T-Lymphocytes / immunology*

Substances

  • Coronavirus Nucleocapsid Proteins
  • Epitopes, T-Lymphocyte
  • HLA-A*02:01 antigen
  • HLA-A2 Antigen
  • Peptide Fragments
  • Phosphoproteins
  • nucleocapsid phosphoprotein, SARS-CoV-2